Garrabou Tornos, Glòria
Mostrant 121 a 140 de 152 resultats
Data | Títol | Autor(s) | Tipus |
---|---|---|---|
2009 | Improvement of Mitochondrial Toxicity in Patients Receiving a Nucleoside Reverse-Transcriptase Inhibitor-Sparing Strategy: Results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA) | Negredo, E,; Miró, Ò.; Rodríguez-Santiago, B.; Garrabou, G.; Estany, C.; Masabeu, A.; Force, L.; Barrufet, P.; Cucurull, J.; Domingo, P.; Alonso-Villaverde, C.; Bonjoch, A.; Morén, C.; Pérez-Álvarez, N.; Clotet, B. | Article |
2009 | Genetic and functional mitochondrial assessment of HIV-infected patients developing HAART-related hyperlactatemia | Garrabou, Gloria; Moren, Constanza; Gallego-Escuredo, Jose Miguel; Milinkovic, Ana; Villarroya, Francesc; Negredo, Eugenia; Giralt, Marta; Vidal, Francesc; Pedrol, Enric; Martinez, Esteban; Cardellach, Francesc; Gatell, Josep Maria; Miro, Oscar | Article |
2008 | Partial immunological and mitochondrial recovery after reducing didanosine doses in patients on didanosine and tenofovir-based regimens | Negredo E; Garrabou G; Puig J; Lòpez S; Morén C; Bellido R; Ayen R; Cardellach F; Miró O; Clotet B | Article |
2008 | Partial immunological and mitochondrial recovery after reducing didanosine doses in patients on didanosine and tenofovir-based regimens | Negredo, Eugenia; Garrabou, Gloria; Puig, Jordi; Lopez, Sonia; Moren, Constanzo; Bellido, Rocio; Ayen, Rafaela; Cardellach, Francesc; Miro, Oscar; Clotet, Bonaventura; | Article |
2008 | Mitochondrial DNA depletion in oocytes of HIV-infected antiretroviral-treated infertile women | Lopez, S.; Coll, O.; Durban, M.; Hernandez, S.; Vidal, R.; Suy, A.; Moren, C.; Casademont, J.; Cardellach, F.; Mataro, D.; Miro, O.; Garrabou, G. | Article |
2008 | Partial immunological and mitochondrial recovery after reducing didanosine doses in patients on didanosine and tenofovir-based regimens | Negredo E, Garrabou G, Puig J, Lòpez S, Morén C, Bellido R, Ayen R, Cardellach F, Miró O, Clotet B | Article |
2007 | HIV-1-infected long-term non-progressors have milder mitochondrial impairment and lower mitochondrially-driven apoptosis in peripheral blood mononuclear cells than typical progressors | Peraire, J.; Miró, O.; Saumoy, M.; Domingo, P.; Pedrol, E.; Villarroya, F.; Martínez, E. et al. | Article |
2007 | The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients | Milinkovic, A.; Martínez, E.; López, S.; de Lazzari, E.; Miró, O.; Vidal, S.; Blanco, J.L.; Garrabou, G.; Laguno, M.; Arnaiz, J.A.; León, A.; Larrousse, M.; Loncà, M.; Mallolas, J.; Gatell, J.M. | Article |
2007 | Neuroleptic treatment effect on mitochondrial electron transport chain: peripheral blood mononuclear cells analysis in psychotic patients | Casademont, J.; Garrabou, G; Miró, Ò.; López, S.; Pons A.; Bernardo M.; Cardellach, F. | Article |
2007 | Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia | Garrabou, G.; Soriano A; López, S.; Guallar JP.; Giralt M; Vilarroya F; Martínez JA; Casademont, J.; Cardellach, F.; Mensa J; Miró, Ò. | Article |
2006 | Longitudinal study on mitochondrial effects of didanosine-tenofovir combination. | López, S.; Negredo, E.; Garrabou, G.; Piug, J.; Ruiz, L.; Sanjurjo, E.; Ramos, X.; Infante, A. B.; Casademont, J.; Cardellach, F.; Clotet, B.; .Miró, Ò. | Article |
2006 | Noninvasive diagnosis of mitochondrial dysfunction in HAAART-related hyperlactatemia | Garrabou, G.; Sanjurjo E; Miró, Ò.; Martínez, E.; Infante A; López, S.; Cardellach, F.; Gatell, J.M.; Casademont, J. | Article |
2006 | A randomized open-label study comparing the impact of reducing the dose of stavudine versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HFV-infected patients: results at 48 weeks | Milinkovic, A.; Martínez, E.; López, S.; de Lazzari, E.; Miró, O.; Vidal, S.; Blanco, J.L.; Garrabou, G.; Laguno, M.; Arnaiz, J.A.; León, A.; Larrousse, M.; Loncà, M.; Mallolas, J.; Gatell, J.M. | Article |
2006 | Non invasive diagnosis of mitochondrial dysfunction in HAART-related hyperlactatemia. | Garrabou G, Sanjurjo E, Miro O, Martinez E, et al. | Article |
2006 | Short communication metabolic and mitochondrial effects of switching antiretroviral-experienced patients to enfuvirtide, tenofovir and saquinavir/ritonavir. | Miro, O.; Garrabou, G.; Lopez, S.; Deig, E.; Vidal, I.; Infante, A. B.; Cardellach, F.; Casademont, J.; Pedrol, E. | Article |
2005 | Protease inhibitors and apoptosis: studies on peripheral blood mononuclear cells (PBMCs). | Lopez S., Garrabou G., Villaroya J. et al. | Article |
2005 | Peripheral blood mononuclear cells of HIV-1-infected patients long-term non-progressors show mild mitochondrial impairment and low mitochondrially driven apoptosis. | Garrabou G., Lopez S., Vidal F., et al. | Article |
2005 | Effects of different doses of didanosine combined with tenofovir on peripheral blood mononuclear cell mitochondrial parameters. | Lopez S., Garrabou G., Negredo E. et al. | Article |
2005 | In vivo effects of highly active antiretroviral therapies containing the protease inhibitor nelfinavir on mitochondrially driven apoptosis | Miró, O.; Villarroya, J.; Garrabou, G.; López, S.; Rodríguez de la Concepción, M.; Pedrol, E.; Martínez, E.; Giralt, M.; Gatell, J. M.; Cardellach, F.; Casademont, J.; Villarroya, F. | Article |
2005 | Tretament of symptomatic hyperlactatemia and lactic acidosis in HIV+ patients under nucleoside reverse transcriptase inhibitors. | Pedrol, E.; Ribell, M.; Deig, E.; Villà, M.C.; Miró, O.; Garrabou, G.; Soler, A. | Article |